An investigation for investors in Humanigen, Inc. (NASDAQ:HGEN) shares over potential securities laws violations by Humanigen, Inc. was announced.

San Diego, CA -- (SBWire) -- 10/07/2021 --An investigation was announced over potential securities laws violations by Humanigen, Inc. in connection with certain financial statements.

Investors who purchased shares of Humanigen, Inc. (NASDAQ: HGEN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Humanigen, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Burlingame, CA based Humanigen, Inc., a clinical stage biopharmaceutical company, develops a portfolio of immuno-oncology and immunology monoclonal antibodies in the United States.

On September 9, 2021, Humanigen, Inc. announced that "the U.S. FDA has declined its request for emergency use authorization of lenzilumab to treat newly hospitalized COVID-19 patients." Humanigen advised investors that "[i]n its letter, FDA stated that it was unable to conclude that the known and potential benefits of lenzilumab outweigh the known and potential risks of its use as a treatment for COVID-19."

Shares of Humanigen, Inc. (NASDAQ: HGEN) declined from $17.18 per sahre on September 2, 2021, to $6.00 per share on September 28, 2021.

Those who purchased shares of Humanigen, Inc. (NASDAQ: HGEN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.